The effects of cantharidin analogues on xanthine oxidase

Anticancer Research

Volumn 17, Issue 3 C, 1997, Pages 2095-2098

  Tsauer, Wei ^a   Lin, Jaung Geng ^a   Lin, Pen Yuan ^b   Hsu, Feng Lin ^b   Chiang, Hsuch Ching ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cantharidin and cantharidimide analogues; Toxic substances; Xanthine oxidase stimulants

Indexed keywords

ALLOPURINOL; CANTHARIDATE DISODIUM; CANTHARIDIN; CANTHARIDIN DERIVATIVE; DEHYDRONORCANTHARIDIN; N (2 PYRIDYL)CANTHARIDIMIDE; N (3 PYRIDYL)CANTHARIDIMIDE; N (4 METHYL 2 PYRIDYL)CANTHARIDIMIDE; N (4 PYRIDYL)CANTHARIDIMIDE; N (5 METHOXY 2 PYRIDYL)CANTHARIDIMIDE; N (5 METHYL 2 PYRIDYL)CANTHARIDIMIDE; N (5 NITRO 2 PYRIDYL)CANTHARIDIMIDE; N (6 METHYL 2 PYRIDYL)CANTHARIDIMIDE; NORCANTHARIDIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; PRIORITY JOURNAL;

ALLOPURINOL; ANTINEOPLASTIC AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; CANTHARIDIN; ENZYME INHIBITORS; KINETICS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; XANTHINE OXIDASE;

EID: 0030878968     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Wang GS: Medical uses of Mylabris in ancient China and recent studies. J Ethnopharmacology 26: 147-162, 1989.
2. Lin PY and Hsu FL: A novel method for the one-step synthesis of cantharidimide by the use of aminopyridine. Annual Meeting of The Chinese Pharmaceutical Society. December 10, 1995. Abstract P.25.
3. Sheu SY and Chiang HC: Inhibitory effects of plant growth regulators on Xanthine oxidase. Anticancer Res 76: 311-316, 1996.
4. Chang WS, Lee YJ, Lu FJ and Chiang HC: Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res 13: 2165-2170, 1993.
5. Al-Khalidi UAS and Geha RS: The sensitivity of serum xanthine oxidase and serum glutamic pyruvic transaminase in detecting liver damage. Clin Chim Acta 14: 833-835, 1966.
6. Shamma AMH, Nasrallah S, Chaglassian T, Kachadurian AK and Al- Khalidi UAS: Serum xanthine oxidase: A sensitive test of acute liver injury. Gastroenterology 48: 226-230, 1965.
7. Ramboer CRH: A sensitive and nonradioactive assay for serum and tissue xanthine oxidase. J Lab and Clin Med 74: 828-835, 1969.
8. Bowman WC and Rand MJ: Textbook of Pharmacology, 2nd ed. In: Chapter 21, The blood: Drugs affecting coagulation, fibrinolysis, haematopoiesis and the functioning of blood cells. Serum enzymes arising from damaged tissues. 21.3 Australia, Blackwell Scientific Publicatins, 1980.
9. Poggetti RS, Moore FA, Moore EE, Koeike K and Banerjee A: Simultaneous liver and lung injury following gut ischaemia is mediated by xanthine oxidase. J Trauma 32: 723-728, 1992.
10. Kokoglu E, Belce A, Ozyurt E and Tepeler Z: Xanthine oxidase levels in human brain tumours. Cancer Lett 50: 179-181, 1990.
11. Brawn K and Fridovich I: DNA strand scission by enzymatically generated oxygen radicals. Arch Biochem Biophy 200: 414-419, 1981.
12. Chiricolo M, Tazzari PL, Abbondanza A, Dinota A and Battelli MG: Cytotoxicity of, and DNA damage by, active oxygen species produced by xanthine oxidase. FEBS Lett 291: 173-176, 1991.
13. Smith HJ: Design of enzyme inhibitors as drugs. In: Xanthine oxidase inhibitors (Sandler M and Smith HJ eds). Oxford, Oxford Unversity Press, 1989, pp 770-779.
14. Bowman WC and Rand MJ: Textbook of Pharmacology, 2nd ed. Chapter 2. Subcellular organisation and cellular metabolism. Degradation of purines. 2.43-2.44, Australia, Blackwell Scientific Publication, 1980.
15. Reilly PM, Schiller HJ and Bulkley GB: Pharmacological approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 161: 488-503, 1991.
16. Bulkley GB: Endothelial xanthine oxidase: a radical transducer of inflammatory signals for reticuloendothelial activation. Br J Surg 80: 684-686, 1993.
17. Floyd RA: Role of oxygen-free radicals in carcinogenesis and brain ischaemia. FASEB J 4: 2587-2597, 1990.
18. Chinese Durg Dictionary, New Edition, Vol.3, p. 1973, Fig.3789 and p.2241, Fig. 4328. Sin Wen Hong Publications Inc, Taipei, Taiwan, 1985.
19. Walter WG and Cole JF: Isolation of Cantharidin from Epicauta pestifera. J Pharm Sciencces 56(2): 174-176, 1967.
20. Lee CH: Clinical uses of Mylabris and development of detoxication. Su-Sang Chinese Medicine 8: 17-19, 1993.
21. Wang GS: Hydrolysis and demethylation of cantharidin on the relief of its urinary irritation. Chinese Pharm. Bull. (18)7: 18-19, 1983.
22. Pratt WB and Ruddon RW: The anticancer drugs. In: Chapter 4. Choice of drugs for cancer chemotherapy (Wheeler RH ed) New York, Oxferd, Oxford Univesity Press, 1979, p.60